Type |
Details |
Score |
Publication |
First Author: |
Russell SE |
Year: |
2016 |
Journal: |
Mucosal Immunol |
Title: |
IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation. |
Volume: |
9 |
Issue: |
5 |
Pages: |
1193-204 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kovach MA |
Year: |
2017 |
Journal: |
Mucosal Immunol |
Title: |
IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia. |
Volume: |
10 |
Issue: |
5 |
Pages: |
1320-1334 |
|
•
•
•
•
•
|
Allele |
Name: |
squamous cell carcinoma antigen recognized by T cells 3; targeted mutation 1.1, Hal E Broxmeyer |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang J |
Year: |
2015 |
Journal: |
Biochem Biophys Res Commun |
Title: |
The NLRP3 inflammasome is dispensable for ER stress-induced pancreatic β-cell damage in Akita mice. |
Volume: |
466 |
Issue: |
3 |
Pages: |
300-5 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Publication |
First Author: |
Shen J |
Year: |
2020 |
Journal: |
Cell Death Dis |
Title: |
Membrane nanotubes facilitate the propagation of inflammatory injury in the heart upon overactivation of the β-adrenergic receptor. |
Volume: |
11 |
Issue: |
11 |
Pages: |
958 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maroni L |
Year: |
2017 |
Journal: |
Am J Pathol |
Title: |
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes. |
Volume: |
187 |
Issue: |
2 |
Pages: |
366-376 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
targeted mutation, congenic, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Publication |
First Author: |
Hoffman H |
Year: |
2012 |
Journal: |
MGI Direct Data Submission |
Title: |
Direct Data Submission 2012/03/01 |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Byun DJ |
Year: |
2024 |
Journal: |
Cell Commun Signal |
Title: |
NLRP3 exacerbates EAE severity through ROS-dependent NET formation in the mouse brain. |
Volume: |
22 |
Issue: |
1 |
Pages: |
96 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Youm YH |
Year: |
2015 |
Journal: |
Nat Med |
Title: |
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. |
Volume: |
21 |
Issue: |
3 |
Pages: |
263-9 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Il36rn/Il36rn Tg(KRT14-Il1f6)1Hblu/? |
Background: |
involves: 129 * C57BL/6 * DBA/2 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Il1rl2/Il1rl2 Tg(KRT14-Il1f6)1Hblu/? |
Background: |
involves: 129 * C57BL/6 * DBA/2 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rag2/Rag2 Tg(KRT14-Il1f6)1Hblu/? |
Background: |
involves: 129S/SvEv * C57BL/6 * DBA/2 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Il1r1/Il1r1 Tg(KRT14-Il1f6)1Hblu/? |
Background: |
involves: 129S1/Sv * C57BL/6 * DBA/2 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Il1rap/Il1rap Tg(KRT14-Il1f6)1Hblu/? |
Background: |
involves: 129S1/Sv * C57BL/6 * DBA/2 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3 |
Background: |
B6N.129-Nlrp3 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Jansen AH |
Year: |
2017 |
Journal: |
Glia |
Title: |
Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific. |
Volume: |
65 |
Issue: |
1 |
Pages: |
50-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Boguslavskyi A |
Year: |
2021 |
Journal: |
Circulation |
Title: |
Phospholemman Phosphorylation Regulates Vascular Tone, Blood Pressure, and Hypertension in Mice and Humans. |
Volume: |
143 |
Issue: |
11 |
Pages: |
1123-1138 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vigne S |
Year: |
2011 |
Journal: |
Blood |
Title: |
IL-36R ligands are potent regulators of dendritic and T cells. |
Volume: |
118 |
Issue: |
22 |
Pages: |
5813-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Palomo J |
Year: |
2018 |
Journal: |
PLoS One |
Title: |
The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression. |
Volume: |
13 |
Issue: |
3 |
Pages: |
e0194667 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kunte SC |
Year: |
2023 |
Journal: |
Front Immunol |
Title: |
No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice. |
Volume: |
14 |
|
Pages: |
1230050 |
|
•
•
•
•
•
|
Publication |
First Author: |
Giannoudaki E |
Year: |
2019 |
Journal: |
Nat Commun |
Title: |
Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction. |
Volume: |
10 |
Issue: |
1 |
Pages: |
4003 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jiang Z |
Year: |
2017 |
Journal: |
J Invest Dermatol |
Title: |
IL-36γ Induced by the TLR3-SLUG-VDR Axis Promotes Wound Healing via REG3A. |
Volume: |
137 |
Issue: |
12 |
Pages: |
2620-2629 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schuster-Gaul S |
Year: |
2020 |
Journal: |
JCI Insight |
Title: |
ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model. |
Volume: |
5 |
Issue: |
2 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Toldo S |
Year: |
2015 |
Journal: |
Cardiovasc Res |
Title: |
Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart. |
Volume: |
105 |
Issue: |
2 |
Pages: |
203-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Colantuoni M |
Year: |
2023 |
Journal: |
Sci Transl Med |
Title: |
Constitutive IL-1RA production by modified immune cells protects against IL-1-mediated inflammatory disorders. |
Volume: |
15 |
Issue: |
698 |
Pages: |
eade3856 |
|
•
•
•
•
•
|
Publication |
First Author: |
Inzaugarat ME |
Year: |
2019 |
Journal: |
Hepatology |
Title: |
NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice. |
Volume: |
69 |
Issue: |
2 |
Pages: |
845-859 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ershaid N |
Year: |
2019 |
Journal: |
Nat Commun |
Title: |
NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis. |
Volume: |
10 |
Issue: |
1 |
Pages: |
4375 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ioannou GN |
Year: |
2023 |
Journal: |
J Lipid Res |
Title: |
Genetic deletion or pharmacologic inhibition of the Nlrp3 inflammasome did not ameliorate experimental NASH. |
Volume: |
64 |
Issue: |
2 |
Pages: |
100330 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qu C |
Year: |
2015 |
Journal: |
FASEB J |
Title: |
NLRP3 mediates osteolysis through inflammation-dependent and -independent mechanisms. |
Volume: |
29 |
Issue: |
4 |
Pages: |
1269-79 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee HE |
Year: |
2019 |
Journal: |
Sci Rep |
Title: |
Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells. |
Volume: |
9 |
Issue: |
1 |
Pages: |
12277 |
|
•
•
•
•
•
|
Publication |
First Author: |
Peng Y |
Year: |
2022 |
Journal: |
Front Immunol |
Title: |
NLRP3+ macrophages aggravate inflammatory cystitis in diabetes. |
Volume: |
13 |
|
Pages: |
1057746 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lakhdari O |
Year: |
2019 |
Journal: |
Sci Rep |
Title: |
Differential Immune Activation in Fetal Macrophage Populations. |
Volume: |
9 |
Issue: |
1 |
Pages: |
7677 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Il36rn/Il36rn<+> Tg(KRT14-Il1f6)1Hblu/? |
Background: |
involves: 129 * C57BL/6 * DBA/2 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Il1rl2/Il1rl2<+> Tg(KRT14-Il1f6)1Hblu/? |
Background: |
involves: 129 * C57BL/6 * DBA/2 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3<+> |
Background: |
involves: 129 |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Allele |
Name: |
histidine ammonia lyase; histidinemia |
Allele Type: |
Spontaneous |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Bourne JH |
Year: |
2023 |
Journal: |
Front Immunol |
Title: |
Megakaryocyte NLRP3 hyperactivation induces mild anemia and potentiates inflammatory response in mice. |
Volume: |
14 |
|
Pages: |
1226196 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vigne S |
Year: |
2012 |
Journal: |
Blood |
Title: |
IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells. |
Volume: |
120 |
Issue: |
17 |
Pages: |
3478-87 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wree A |
Year: |
2018 |
Journal: |
Hepatology |
Title: |
NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice. |
Volume: |
67 |
Issue: |
2 |
Pages: |
736-749 |
|
•
•
•
•
•
|
Publication |
First Author: |
Takaishi M |
Year: |
2018 |
Journal: |
J Invest Dermatol |
Title: |
Regnase-1, an Immunomodulator, Limits the IL-36/IL-36R Autostimulatory Loop in Keratinocytes to Suppress Skin Inflammation. |
Volume: |
138 |
Issue: |
6 |
Pages: |
1439-1442 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bozoyan L |
Year: |
2015 |
Journal: |
J Neuroinflammation |
Title: |
Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis. |
Volume: |
12 |
|
Pages: |
173 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ma JH |
Year: |
2022 |
Journal: |
EBioMedicine |
Title: |
Therapeutic effect of NLRP3 inhibition on hearing loss induced by systemic inflammation in a CAPS-associated mouse model. |
Volume: |
82 |
|
Pages: |
104184 |
|
•
•
•
•
•
|
Publication |
First Author: |
Douglas T |
Year: |
2015 |
Journal: |
J Immunol |
Title: |
The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice. |
Volume: |
195 |
Issue: |
5 |
Pages: |
2365-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wali JA |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Activation of the NLRP3 inflammasome complex is not required for stress-induced death of pancreatic islets. |
Volume: |
9 |
Issue: |
11 |
Pages: |
e113128 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, targeted mutation, congenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Kajiwara Y |
Year: |
2014 |
Journal: |
J Immunol |
Title: |
A critical role for human caspase-4 in endotoxin sensitivity. |
Volume: |
193 |
Issue: |
1 |
Pages: |
335-43 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Il1rap/Il1rap<+> Tg(KRT14-Il1f6)1Hblu/? |
Background: |
involves: 129S1/Sv * C57BL/6 * DBA/2 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3<+> Tg(Zp3-cre)3Mrt/? |
Background: |
involves: 129/Sv * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3<+> Tg(CAG-cre/Esr1*)5Amc/? |
Background: |
involves: 129/Sv * C57BL/6 * CBA |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3<+> Tg(CAG-cre/Esr1*)5Amc/? |
Background: |
involves: 129/Sv * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3<+> Tg(CAG-cre/Esr1*)5Amc/? |
Background: |
involves: 129/Sv * C57BL/6 * CBA |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3<+> Tg(CAG-cre/Esr1*)5Amc/? |
Background: |
involves: 129/Sv * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3 Vsig4/Vsig4 |
Background: |
B6.Cg-Nlrp3 Vsig4 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock, spontaneous mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Hal/Hal |
Background: |
involves: C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Baedeker M |
Year: |
2002 |
Journal: |
Eur J Biochem |
Title: |
Structures of two histidine ammonia-lyase modifications and implications for the catalytic mechanism. |
Volume: |
269 |
Issue: |
6 |
Pages: |
1790-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Appert C |
Year: |
1994 |
Journal: |
Eur J Biochem |
Title: |
Structural and catalytic properties of the four phenylalanine ammonia-lyase isoenzymes from parsley (Petroselinum crispum Nym.). |
Volume: |
225 |
Issue: |
1 |
Pages: |
491-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rachid S |
Year: |
2006 |
Journal: |
Chem Biol |
Title: |
Molecular and biochemical studies of chondramide formation-highly cytotoxic natural products from Chondromyces crocatus Cm c5. |
Volume: |
13 |
Issue: |
6 |
Pages: |
667-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Krug D |
Year: |
2009 |
Journal: |
Chembiochem |
Title: |
Discovery of additional members of the tyrosine aminomutase enzyme family and the mutational analysis of CmdF. |
Volume: |
10 |
Issue: |
4 |
Pages: |
741-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Poppe L |
Year: |
2001 |
Journal: |
Curr Opin Chem Biol |
Title: |
Methylidene-imidazolone: a novel electrophile for substrate activation. |
Volume: |
5 |
Issue: |
5 |
Pages: |
512-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alunni S |
Year: |
2003 |
Journal: |
Arch Biochem Biophys |
Title: |
Mechanisms of inhibition of phenylalanine ammonia-lyase by phenol inhibitors and phenol/glycine synergistic inhibitors. |
Volume: |
412 |
Issue: |
2 |
Pages: |
170-5 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This family includes phenylalanine ammonia-lyase, (PAL; ), histidine ammonia-lyase, (HAL; ), and tyrosine aminomutase, () [, , ].PAL and HAL are members of the Lyase class I_like superfamily of enzymes that, catalyze similar beta-elimination reactions and are active as homotetramers. Both PAL and HAL contain a catalytic Ala-Ser-Gly triad that is post-translationally cyclised []. PAL is a key biosynthetic catalyst in phenylpropanoid assembly in plants and fungi, and is involved in the biosynthesis of a wide variety of secondary metabolites such as flavanoids, furanocoumarin phytoalexins and cell wall components. These compounds are important for normal growth and in responses to environmental stress. HAL catalyses the first step in histidine degradation, the removal of an ammonia group from histidine to produce urocanic acid. The core domain in PAL and HAL share about 30% sequence identity, with PAL containing an additional approximately 160 residues extending from the common fold []. Tyrosine 2,3-aminomutase has aminomutase activity and, to a much lesser extent, ammonia-lyase activity [].PAL is being explored as enzyme substitution therapy for Phenylketonuria (PKU), a disorder which involves an inability to metabolize phenylalanine. HAL failure in humans results in the disease histidinemia [, , , ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang X |
Year: |
2015 |
Journal: |
Cancer Cell |
Title: |
IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses. |
Volume: |
28 |
Issue: |
3 |
Pages: |
296-306 |
|
•
•
•
•
•
|
Publication |
First Author: |
Erlich Z |
Year: |
2019 |
Journal: |
Nat Immunol |
Title: |
Macrophages, rather than DCs, are responsible for inflammasome activity in the GM-CSF BMDC model. |
Volume: |
20 |
Issue: |
4 |
Pages: |
397-406 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xiao J |
Year: |
2018 |
Journal: |
PLoS Biol |
Title: |
Gasdermin D mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice. |
Volume: |
16 |
Issue: |
11 |
Pages: |
e3000047 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shim DW |
Year: |
2024 |
Journal: |
Exp Mol Med |
Title: |
Deficiency of circadian clock gene Bmal1 exacerbates noncanonical inflammasome-mediated pyroptosis and lethality via Rev-erbα-C/EBPβ-SAA1 axis. |
Volume: |
56 |
Issue: |
2 |
Pages: |
370-382 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ngo VL |
Year: |
2020 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
IL-36R signaling integrates innate and adaptive immune-mediated protection against enteropathogenic bacteria. |
Volume: |
117 |
Issue: |
44 |
Pages: |
27540-27548 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang P |
Year: |
2022 |
Journal: |
Front Immunol |
Title: |
Persistent expression of NLRP3 in spinal microglia promotes development of lumbar disc degeneration. |
Volume: |
13 |
|
Pages: |
1064303 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bonar SL |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. |
Volume: |
7 |
Issue: |
4 |
Pages: |
e35979 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang Y |
Year: |
2018 |
Journal: |
EMBO Mol Med |
Title: |
Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. |
Volume: |
10 |
Issue: |
4 |
|
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3<+> Lyz2/Lyz2<+> |
Background: |
involves: 129/Sv * 129P2/OlaHsd * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3<+> Lyz2/Lyz2<+> |
Background: |
involves: 129/Sv * 129P2/OlaHsd * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3<+> Rag1/Rag1 Lyz2/Lyz2<+> |
Background: |
involves: 129/Sv * 129P2/OlaHsd * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nlrp3/Nlrp3 Lyz2/Lyz2<+> |
Background: |
involves: 129 * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Sart3/Sart3<+> Tg(Tek-cre)1Ywa/? |
Background: |
involves: C57BL/6 * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
44
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
59
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Y |
Year: |
2013 |
Journal: |
Structure |
Title: |
Structural insights into the intrinsic self-assembly of Par-3 N-terminal domain. |
Volume: |
21 |
Issue: |
6 |
Pages: |
997-1006 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This domain is found in eukaryotes and is about 150 amino acids in length. It has a conserved GILD sequence motif. Some proteins containing this domain are essential for cell polarity establishment and maintenance such as Par3 (partitioning defective), and some are involved in conversion of histidine into ammonia (a crucial step for forming histamine in humans) such as Histidine ammonia lyase (HAL). This N-terminal domain is found to mediate oligomerization critical for the membrane localization of Par-3. It is also found to possess a self-association capacity via a front-to-back mode in Par-3 and HAL proteins. However, unlike the Par-3 N-terminal domain which self-assembles into a left-handed helical filament, the HAL N-terminal domain does not tend to form a helical filament but rather self-assembles into circular oligomeric particles. This has been suggested to be likely due to the absence of equivalent charged residues that are essential for the longitudinal packing of the Par-3 N-terminal domain filament []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang X |
Year: |
2019 |
Journal: |
Sci Adv |
Title: |
VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages. |
Volume: |
5 |
Issue: |
1 |
Pages: |
eaau7426 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stackowicz J |
Year: |
2021 |
Journal: |
J Exp Med |
Title: |
Neutrophil-specific gain-of-function mutations in Nlrp3 promote development of cryopyrin-associated periodic syndrome. |
Volume: |
218 |
Issue: |
10 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Rhoads JP |
Year: |
2017 |
Journal: |
J Immunol |
Title: |
Oxidized Low-Density Lipoprotein Immune Complex Priming of the Nlrp3 Inflammasome Involves TLR and FcγR Cooperation and Is Dependent on CARD9. |
Volume: |
198 |
Issue: |
5 |
Pages: |
2105-2114 |
|
•
•
•
•
•
|
Publication |
First Author: |
Patrick GJ |
Year: |
2021 |
Journal: |
J Clin Invest |
Title: |
Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease. |
Volume: |
131 |
Issue: |
5 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Brydges SD |
Year: |
2013 |
Journal: |
J Clin Invest |
Title: |
Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies. |
Volume: |
123 |
Issue: |
11 |
Pages: |
4695-705 |
|
•
•
•
•
•
|
Publication |
First Author: |
McGeough MD |
Year: |
2012 |
Journal: |
J Immunol |
Title: |
Cutting edge: IL-6 is a marker of inflammation with no direct role in inflammasome-mediated mouse models. |
Volume: |
189 |
Issue: |
6 |
Pages: |
2707-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Marneros AG |
Year: |
2018 |
Journal: |
FASEB J |
Title: |
Effects of chronically increased VEGF-A on the aging heart. |
Volume: |
32 |
Issue: |
3 |
Pages: |
1550-1565 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guo S |
Year: |
2015 |
Journal: |
PLoS Pathog |
Title: |
The NLRP3 Inflammasome and IL-1β Accelerate Immunologically Mediated Pathology in Experimental Viral Fulminant Hepatitis. |
Volume: |
11 |
Issue: |
9 |
Pages: |
e1005155 |
|
•
•
•
•
•
|
Publication |
First Author: |
McGeough MD |
Year: |
2017 |
Journal: |
J Clin Invest |
Title: |
TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies. |
Volume: |
127 |
Issue: |
12 |
Pages: |
4488-4497 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhong Z |
Year: |
2016 |
Journal: |
Cell |
Title: |
NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. |
Volume: |
164 |
Issue: |
5 |
Pages: |
896-910 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sanchez-Lopez E |
Year: |
2019 |
Journal: |
Cell Metab |
Title: |
Choline Uptake and Metabolism Modulate Macrophage IL-1β and IL-18 Production. |
Volume: |
29 |
Issue: |
6 |
Pages: |
1350-1362.e7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guo J |
Year: |
2024 |
Journal: |
Mol Immunol |
Title: |
MS4A6D Promotes carrageenan-induced footpad swelling in mice through enhancing macrophages-derived inflammation. |
Volume: |
169 |
|
Pages: |
28-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cui S |
Year: |
2020 |
Journal: |
Sci Adv |
Title: |
CD1d1 intrinsic signaling in macrophages controls NLRP3 inflammasome expression during inflammation. |
Volume: |
6 |
Issue: |
43 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Weiss ES |
Year: |
2018 |
Journal: |
Blood |
Title: |
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. |
Volume: |
131 |
Issue: |
13 |
Pages: |
1442-1455 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shahzad K |
Year: |
2022 |
Journal: |
Kidney Int |
Title: |
Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease. |
Volume: |
102 |
Issue: |
4 |
Pages: |
766-779 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guo C |
Year: |
2018 |
Journal: |
Immunity |
Title: |
Cholesterol Homeostatic Regulator SCAP-SREBP2 Integrates NLRP3 Inflammasome Activation and Cholesterol Biosynthetic Signaling in Macrophages. |
Volume: |
49 |
Issue: |
5 |
Pages: |
842-856.e7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Malsy J |
Year: |
2020 |
Journal: |
Elife |
Title: |
Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularization. |
Volume: |
9 |
|
|
|
•
•
•
•
•
|